Fortress Biotech, Inc. (FBIO)
2.93
+0.06
(+2.09%)
USD |
NASDAQ |
Aug 24, 16:00
2.93
0.00 (0.00%)
After-Hours: 20:00
Fortress Biotech Total Liabilities (Quarterly) : 110.63M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 110.63M |
| March 31, 2026 | 154.50M |
| December 31, 2025 | 123.36M |
| September 30, 2025 | 116.22M |
| June 30, 2025 | 122.51M |
| March 31, 2025 | 145.58M |
| December 31, 2024 | 145.87M |
| September 30, 2024 | 139.82M |
| June 30, 2024 | 160.28M |
| March 31, 2024 | 168.58M |
| December 31, 2023 | 165.94M |
| September 30, 2023 | 163.79M |
| June 30, 2023 | 196.66M |
| March 31, 2023 | 243.74M |
| December 31, 2022 | 244.28M |
| September 30, 2022 | 222.21M |
| June 30, 2022 | 216.25M |
| March 31, 2022 | 214.35M |
| December 31, 2021 | 170.63M |
| September 30, 2021 | 195.36M |
| June 30, 2021 | 169.86M |
| March 31, 2021 | 146.82M |
| December 31, 2020 | 136.41M |
| September 30, 2020 | 119.73M |
| June 30, 2020 | 151.72M |
| Date | Value |
|---|---|
| March 31, 2020 | 153.47M |
| December 31, 2019 | 153.89M |
| September 30, 2019 | 146.59M |
| June 30, 2019 | 137.44M |
| March 31, 2019 | 149.83M |
| December 31, 2018 | |
| September 30, 2018 | 140.28M |
| June 30, 2018 | 140.60M |
| March 31, 2018 | 157.53M |
| December 31, 2017 | 125.45M |
| September 30, 2017 | 123.83M |
| June 30, 2017 | 99.23M |
| March 31, 2017 | 85.59M |
| December 31, 2016 | 87.76M |
| September 30, 2016 | 70.58M |
| June 30, 2016 | 39.85M |
| March 31, 2016 | 34.00M |
| December 31, 2015 | 34.34M |
| September 30, 2015 | 31.94M |
| June 30, 2015 | 28.49M |
| March 31, 2015 | 30.26M |
| December 31, 2014 | 18.81M |
| September 30, 2014 | 18.75M |
| June 30, 2014 | 18.50M |
| March 31, 2014 | 19.41M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Inovio Pharmaceuticals, Inc. | 45.02M |
| Ironwood Pharmaceuticals, Inc. | 446.97M |
| Kura Oncology, Inc. | 539.36M |
| Spero Therapeutics, Inc. | 8.562M |
| Cue Biopharma, Inc. | 28.40M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 316.72M |
| Shareholders Equity (Quarterly) | 164.14M |
| Debt to Equity Ratio | 0.3248 |
| Current Ratio | 3.959 |
| Net Debt Paydown Yield | 4.10% |